Issues
February 2009 COMMENTARY
- A Blueprint for Pharmacy Benefit Managers to Increase Value
William H. Shrank, MD, MSHS; Michael E. Porter, PhD, MBA; Sachin H. Jain, MD, MBA; and Niteesh K. Choudhry, MD, PhD Pharmacy benefit managers can increase value through promoting use of cost-effective medications, timely initiation of essential therapy, and adherence to that therapy. Full Text PDF
- Cost-Effectiveness of Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease
Yuji Oba, MD Continuous home oxygen therapy for chronic obstructive pulmonary disease seems more cost-effective than other health technologies covered by Medicare, while nocturnal oxygen therapy is not. Full Text PDF
- "No-Shows": Who Fails to Follow Up With Initial Behavioral Health Treatment?
Kara Zivin, PhD; Paul N. Pfeiffer, MD; Ryan J. McCammon, AB; Janet S. Kavanagh, MS; Heather Walters, MS; Deborah E. Welsh, MS; Duane J. Difranco, MD; Michele M. Brown, MSW; and Marcia Valenstein, MD Patients who obtained authorization but did not get initial mental health treatment needed treatment as much as or more than patients who presented for care. Full Text PDF
- Impact of 2 Employer-Sponsored Population Health Management Programs on Medical Care Cost and Utilization
Soeren Mattke, MD, DSc; Seth A. Serxner, PhD, MPH; Sarah L. Zakowski, BA; Arvind K. Jain, MS; and Daniel B. Gold, PhD Integrated health management programs combining disease prevention and disease management services, although popular with employers, may not save money, at least in their first year. Full Text PDF
- The Effects of Antihypertensive Step-Therapy Protocols on Pharmaceutical and Medical Utilization and Expenditures
Tami L. Mark, PhD, MBA; Teresa B. Gibson, PhD; and Kimberly A. McGuigan, PhD Step therapy with antihypertensives may lead to medication cost savings but may have unintended effects on other medical care utilization and spending. Full Text PDF Appendix
- Provider Organization Performance Assessment Utilizing Diabetes Physician Recognition Program
Bruce Wall, MD, MMM; Evelyn Chiao, PharmD; Craig A. Plauschinat, PharmD, MPH; Retrospective chart review to assess the impact of the Diabetes Physician Recognition Program showed that most patients achieved control levels recommended by national treatment guidelines. Full Text PDF
- Reporting Hospitals" Antibiotic Timing in Pneumonia: Adverse Consequences for Patients?
Mark W. Friedberg, MD, MPP; Ateev Mehrotra, MD, MPH; and Jeffrey A. Linder, MD, MPH Nationwide data on hospital emergency department visits reveal little evidence of unintended adverse consequences associated with publicly reporting hospitals’ antibiotic timing in pneumonia. Full Text PDF Appendix
|
|